Federal Register / Vol. 63, No. 87 /Wednesday, May 6, 1998 / Notices 25059

Respondents: States, Puerto Rico, Guam, the Virgin Islands, and the District of Columbia.

ANNUAL BURDEN ESTIMATES

Instrument Number of

respondents

Number of

responses per

respondent

Average

burden per

respondent

Total

burden

hours

TANF High Performance Bonus Report (ACF–200) ........................................ 54 4 14 3,024

Emergency TANF Data Report (ACF–198) ..................................................... 17 4 218.5 14,858

Estimated Total Burden Hours:

17,882.

Note: Competition for a High Performance

Bonus is optional. This estimate assumes that

all 50 States, the District of Columbia, Guam,

Puerto Rico, and the Virgin Islands would

apply and be required to submit the TANF

High Performance Bonus Report; however,

only those competing jurisdictions operating

separate State programs comparable to TANF

would be required to submit the Emergency

TANF Data Report for those separate State

programs; those competing jurisdictions

where the separate State programs are not

comparable to the TANF program or would

be required to submit other supplement data.

Additional Information

ACF is requesting that OMB grant a

180 day approval for this information

collection under procedures for

emergency processing by June 1, 1998.

A copy of this information collection,

with applicable supporting

documentation, may be obtained by

calling the Administration for Children

and Families, Acting Reports Clearance

Officer, Bob Sargis at (202) 690–7275.

Comments and questions about the

information collection described above

should be directed to the Office of

Information and Regulatory Affairs prior

to June 1, 1998, Attn: OMB Desk Officer

of ACF, Office of Management and

Budget, Paperwork Reduction Project,

725 17th Street N.W., Washington, D.C.

20503, (202) 690–7275.

Dated: April 29, 1998.

Bob Sargis,

Acting Reports Clearance Officer.

[FR Doc. 98–11961 Filed 5–5–98; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 97N–0451]

Microbial Safety of Produce; Notice of

Public Meetings

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

three public meetings to discuss the

President’s initiative to ensure the safety

of imported and domestic fruits and

vegetables and other foods, and

specifically the microbial safety of

produce. The meetings are intended to

give an overview of, and obtain

comment on, the general draft guide

entitled ‘‘Guidance for Industry: Guide

to Minimize Microbial Food Safety

Hazards for Fresh Fruits and

Vegetables’’ (the proposed guide). One

of the meetings will focus primarily on

obtaining comment from the

international audience.

DATES: See Table 1 in the

SUPPLEMENTARY INFORMATION section of

this document.

ADDRESSES: Submit written comments

on the meetings and on the proposed

guide to the Dockets Management

Branch (HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857. Submit

written requests for single copies of the

proposed guide to Lou Carson, Center

for Food Safety and Applied Nutrition,

200 C St. SW., rm. 3812, Washington,

DC 20204, 202–260–8920. Send one

self-adhesive address label to assist that

office in processing your request.

Comments on the meetings or on the

proposed guide should be identified

with the docket number found in

brackets in the heading of this

document.

The meetings will be at the addresses

and on the dates listed in Table 1.

Registration is not required.

FOR FURTHER INFORMATION CONTACT:

Camille E. Brewer, Center for Food

Safety and Applied Nutrition (HFS–32),

Food and Drug Administration, 200 C

St. SW., Washington, DC 20204, 202–

260–1784, FAX 202–260–9653, e-mail

cbrewer@bangate.fda.gov.

SUPPLEMENTARY INFORMATION:

I. Background

On October 2, 1997, the President

announced the ‘‘Initiative to Ensure the

Safety of Imported and Domestic Fruits

and Vegetables’’ (fresh produce safety

initiative). As part of the fresh produce

safety initiative, the President directed

the Secretary of Health and Human

Services (DHHS) and the Secretary of

the U.S. Department of Agriculture

(USDA), in cooperation with the

agricultural community, to issue, within

1 year, guidance on good agricultural

practices and good manufacturing

practices for fresh fruits and vegetables.

FDA is coordinating the effort for

DHHS.

As part of this effort, FDA and USDA

held a series of public meetings between

November 17, 1997, and December 12,

1997, to provide the details on a broad

approach on how to minimize microbial

contamination through the control of

water, manure, worker health and

hygiene, field and facility sanitation,

and transportation. A draft guide

entitled ‘‘Working Draft: Guide to

Minimize Microbial Food Safety

Hazards for Fresh Fruit and Vegetables’’

was made available on FDA’s World

Wide Web (WWW) home page (http://

www.fda.gov) and at each public

meeting. Transcripts of these meetings

and all comments received on the

working draft of the proposed guide are

on file in the Dockets Management

Branch (address above) under the

docket number found in brackets in the

heading of this document and are

accessible via the FDA home page on

the WWW (http://www.fda.gov/ohrms/

dockets/default.htm).

In the Federal Register of April 13,

1998 (63 FR 18029), FDA published a

notice of availability of the proposed

guide that responded to comments

received on the working draft of the

guide. The revised draft entitled

‘‘Guidance for Industry: Guide to

Minimize Microbial Food Safety

Hazards for Fresh Fruits and

Vegetables’’ is available on the FDA

home page on the WWW (http://

www.fda.gov/ohrms/dockets/

default.htm).

The public meetings will include an

overview of the President’s fresh

produce safety initiative and a review of

the proposed guide. The meetings are

intended to obtain comment on the

specific recommendations made in the
25060 Federal Register / Vol. 63, No. 87 /Wednesday, May 6, 1998 / Notices

proposed guide and how the

recommendations might best be applied.

II. Requests for Comments

Interested persons may submit written

comments on the meetings and on the

proposed guide to the Dockets

Management Branch (address above).

Two copies of any comments are to be

submitted except that individuals may

submit one copy. Comments are to be

identified with the docket number

found in brackets in the heading of this

document. A copy of the proposed

guide and received comments are

available for public examination in the

office above between 9 a.m. and 4 p.m.,

Monday through Friday.

III. Transcripts

Transcripts of the meetings may be

requested in writing from the Freedom

of Information Office (HFI–35), Food

and Drug Administration, 5600 Fishers

Lane, rm. 12A–16, Rockville, MD 20857,

approximately 15 working days after

each meeting at a cost of 10 cents per

page. The transcripts of the meetings

will be available for public examination

at the Dockets Management Branch

(address above).

Persons requiring a sign language

interpreter or other special

accommodations should notify the

contact person referenced above by

February 19, 1998.

IV. Electronic Access

Transcripts of the meetings will be

available on the Internet using the

WWW (http://www.fda.gov/ohrms/

dockets/default.htm). The proposed

guide is available at the same address.

Table 1.—Public Meetings

Meeting address Date and local time FDA contact person

WASHINGTON, DC: Department of Health

and Human Services, Hubert Humphrey

Bldg., rm. 800, 200 and Independence

Ave., Washington, DC 20201.

May 19, 1998, Tuesday, 10 a.m. to 5 p.m. Marilyn Veek, Food and Drug Administration,

Office of International Affairs (HFG–1),

5600 Fishers Lane, Rockville, MD 20857,

301–827–0906

MIAMI: Miami Dade County Cooperative Extension Service Agriculture Center,18710

SW. 288th St., Homestead, FL 33033.

May 21, 1998, Thursday, 10 a.m. to 5 p.m. Estela Niella-Brown, Food and Drug Administration, P.O. Box 59–2256, Miami, FL

33159–2256, 305–526–2800, ext. 930.

SAN DIEGO: Malcolm X Branch Library Multipurpose Room, 5148 Market St., San

Diego, CA 92114.

May 27, 1998, Wednesday, 10 a.m. to 5 p.m. Rosario Quintanilla Vior, Food and Drug Administration, 19900 MacArthur Blvd., suite

300, Irvine, CA 92612–2445, 714–798–

7607.

Dated: May 1, 1998.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 98–12116 Filed 5–4–98; 1:10 pm]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Surveillance Updates and Trends;

Notice of Workshops

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

The Food and Drug Administration

(FDA), (Office of Regulatory Affairs,

Atlanta and Florida District Offices, and

the Center for Biologics Evaluation and

Research) is announcing two Workshops

entitled ‘‘Surveillance Updates and

Trends,’’ for persons involved in

licensed and unlicensed blood banks,

plasma centers, and transfusion services

served by FDA’s Southeast Regional

Office. The purpose of these workshops

is to provide industry with information

regarding regulations, surveillance

updates, and trends on error and

accident reporting, recalls, and

fatalities.

Date and Time: The workshops will

be held on Tuesday, June 23, 1998, 8

a.m. to 5:30 p.m., Doraville, GA (Atlanta

area), and on Thursday, June 25, 1998,

8 a.m. to 5:30 p.m., Altamonte Springs,

FL (Orlando area).

Location: On June 23, 1998, the

workshop will be held at the Ramada

Plaza Hotel, 4001 Presidential Pkwy.,

Doraville, GA, 770–216–9500. On June

25, 1998, the workshop will be held at

the Orlando North Hilton, 350 S. North

Lake Blvd., Altamonte Springs, FL, 407–

830–1985.

Contact: Barbara Ward-Groves, Food

and Drug Administration, 60 Eighth St.

NE., Atlanta GA 30309, 404–347–4001,

ext. 5256, FAX 404–347–4349, or

Sharon Schneider, Center for Biologics

Evaluation and Research, Food and

Drug Administration (HFM–43), 1401

Rockville Pike, suite 200N, Rockville,

MD 20852–1448, 301–827–3840, FAX

301–827–3843.

Registration: For the June 23, 1998,

Atlanta area workshop, fax registration

information (including name, title, firm

name, address, telephone, and fax

number) to Vincent Williams,

Registration Coordinator at 404–347–

1913 or 404–347–4206 by May 15, 1998.

For the June 25, 1998, Orlando area

workshop, fax registration information

(including name, title, firm name,

address, telephone, and fax number) to

Ron Jackson, Registration Coordinator at

407–475–4768 by May 15, 1998. There

is no registration fee for these

workshops. Space is limited; therefore,

interested parties are encouraged to

register early.

SUPPLEMENTARY INFORMATION: These

workshops comply with the Small

Business Regulatory Enforcement

Fairness Act (Pub. L. 104–121) that

requires outreach activities by

Government agencies directed to small

businesses. These workshops are

intended to provide an exchange of

information between FDA and the

biologics industry on updates and trend

information regarding surveillance

functions. The topics to be discussed

include the following: (1) The current

regulation and proposed rule for error

and accident reporting; (2) recall

definitions, i.e., differences between

FDA and firm-initiated recalls, and (3)

the current regulation for reporting

fatalities, to include information

pertaining to the investigative followup.

Trend information will identify the

types of events occurring in the past few

years in each of the above three areas.

Dated: April 29, 1998.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 98–11983 Filed 5–5–98; 8:45 am]

BILLING CODE 4160–01–F